Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst Marion Roussel Research Building Opens


BRIDGEWATER, NJ--Pharmaceutical company Hoechst Marion Roussel announced the opening of a $45 million drug innovation facility that it said will double the company's research capacity here. The 150,000-square-foot facility will house 200 researchers dedicated to lead generation functions, including analytical and medicinal chemistry, automated chemical synthesis, biotechnology, automated screening, and molecular modeling.

Company spokesman Ron Rogers told BioInform the building will house a "significant" bioinformatics staff, but that Hoechst's major bioinformatics thrust is taking place in Cambridge, Mass., at the Hoechst-Ariad Research Center. Rogers said bioinformatics and knowledge management are important elements of Hoechst's strategy: "Everyone has access to technology. We think knowledge management will separate the winners from the losers."

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.